Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
10 04 2021
Historique:
received: 23 12 2020
accepted: 30 03 2021
entrez: 11 4 2021
pubmed: 12 4 2021
medline: 29 6 2021
Statut: epublish

Résumé

To investigate the contribution of unaffected cardiomyocytes in Fabry disease cardiomyopathy. Left ventricular (LV) endomyocardial biopsies from twenty-four females (mean age 53 ± 11 ys) with Fabry disease cardiomyopathy were studied. Diagnosis of FD was based on the presence of pathogenic GLA mutation, Patients were divided in four groups according with LV maximal wall thickness (MWT): group 1 MWT ≤ 10.5 mm, group 2 MWT 10.5-15 mm, group 3 MWT 16-20 mm, group 4 MWT > 20 mm. At histology mosaic of affected and unaffected cardiomyocytes was documented. Unaffected myocytes' size ranged from normal to severe hypertrophy. Hypertrophy of unaffected cardiomyocytes correlated with severity of MWT (p < 0.0001, Sperman r 0,95). Hypertrophy of unaffected myocytes appear to concur to progression and severity of FDCM. It is likely a paracrine role from neighboring affected myocytes.

Identifiants

pubmed: 33838691
doi: 10.1186/s13023-021-01803-7
pii: 10.1186/s13023-021-01803-7
pmc: PMC8037917
doi:

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169

Références

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7
pubmed: 18287059
Orphanet J Rare Dis. 2010 Nov 22;5:30
pubmed: 21092187
Orphanet J Rare Dis. 2016 Jun 29;11(1):88
pubmed: 27356758
Circulation. 2004 Aug 31;110(9):1047-53
pubmed: 15313943
Circulation. 2002 Mar 26;105(12):1407-11
pubmed: 11914245
Circulation. 2009 May 19;119(19):2561-7
pubmed: 19414635
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):839-44
pubmed: 16469946
J Mol Med (Berl). 2005 Aug;83(8):647-54
pubmed: 15806320
BMC Genomics. 2019 Mar 12;20(1):201
pubmed: 30871455
Kidney Int. 2011 Mar;79(6):663-670
pubmed: 21160462
J Med Genet. 2003 Aug;40(8):e103
pubmed: 12920095
Mol Genet Metab. 2017 Jan - Feb;120(1-2):57-61
pubmed: 27773586
J Med Genet. 1996 Aug;33(8):682-8
pubmed: 8863162

Auteurs

Cristina Chimenti (C)

Department of Clinical, Internal, Anesthesiologist and Cardiovascular Sciences, Sapienza University, Viale del Policlinico 155, 00161, Rome, Italy.
Cellular and Molecular Cardiology Lab, IRCCS L. Spallanzani, Rome, Italy.

Romina Verardo (R)

Cellular and Molecular Cardiology Lab, IRCCS L. Spallanzani, Rome, Italy.

Andrea Frustaci (A)

Department of Clinical, Internal, Anesthesiologist and Cardiovascular Sciences, Sapienza University, Viale del Policlinico 155, 00161, Rome, Italy. biocard@inmi.it.
Cellular and Molecular Cardiology Lab, IRCCS L. Spallanzani, Rome, Italy. biocard@inmi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH